<DOC>
	<DOCNO>NCT00546754</DOCNO>
	<brief_summary>To evaluate blood pressure efficacy losartan valsartan equivalent dosage 3 month treatment .</brief_summary>
	<brief_title>BP-EASE -Effectiveness Losartan 50 mg/Hydrochlorothiazide ( HCTZ ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated Needed Patients With Essential Hypertension Not Controlled Monotherapy ( 0954A-333 )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>An Adult Patient 18 75 Years Of Age Patient essential hypertension receive antihypertensive agent monotherapy least 4 week antihypertensive agent ( ) discontinue whose blood pressure control : Either systolic diastolic blood pressure &gt; 140/90 mm Hg 180/110 mm Hg ( inclusive ) Either systolic diastolic blood pressure &gt; 130/80 mm Hg 160/100 mm Hg ( inclusive ) diabetic patient Patient male female highly unlikely conceive fall one category list : Surgically sterilize female Postmenopausal female &gt; 45 year age &gt; 2 year since last menses Nonsterilized premenopausal female agrees : ( 1 ) use 2 adequate method contraception prevent pregnancy [ either 2 barrier method barrier method plus hormonal method ] ; ( 2 ) abstain heterosexual activity throughout study start Visit 1 14 day last dose study medication ; ( 3 ) engage heterosexual activity surgically sterilize male partner ( ) throughout study start Visit 1 14 day last dose study medication Patient judge otherwise good , stable health basis medical history physical examination Known secondary hypertension aetiology ( e.g. , uncorrected renal artery stenosis , malignant hypertension , hypertensive encephalopathy ) Patient Needing An Initiation Of A Lipid Lowering Agent Or A Modification Of His Lipid Therapy At Visit 1 Or During The Study Period ( 12 Weeks ) Patient take allopurinol Patient Previously Shown To Be Intolerant To Any Component Of Losartan Valsartan , Or HCTZ Or With A Documented History Of Angioedema/Anaphylaxis Patient With Confirmed Clinically Significant Renal Or Hepatic Dysfunction And/Or Electrolyte Imbalance Laboratory Test Within The Last 3 Months Prior To Visit 1 : Serum Creatinine &gt; 130 Umol/L Or Creatinine Clearance &lt; 45 Ml/Min , Aspartate transaminase ( AST ) &gt; 2 Times Above The Normal Range , Alanine transaminase ( ALT ) &gt; 2 Times Above The Normal Range , Serum Potassium &lt; 3.5 Or &gt; 5.5 Meq/L Patient osteoarthritis undergone hip knee replacement within last 4 month Patient chronic inflammatory condition rheumatoid arthritis , lupus , inflammatory bowel disease need chronic inflammatory therapy prednisone steroid agent Patient symptomatic heart failure ( class 3 4 ) Patient history stroke within last 6 month Patient coronary heart disease : undergone percutaneous coronary angioplasty , coronary artery bypass , past myocardial infarction , occur less 6 month prior visit 1 unstable angina Patient participate investigational drug program last 30 day ( prior Visit 1 ) Unable unwilling comply protocol , therefore likely leave trial completion Patient intend move vacation away home course study would interfere schedule visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>